Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner.
Ware MB, Phillips M, McQuinn C, Zaidi MY, Knochelmann HM, Greene E, Robinson B, Herting CJ, Mace TA, Chen Z, Zhang C, Farren MR, Ruggieri AN, Bowers JS, Shakya R, Farris AB, Young G, Carson WE 3rd, El-Rayes B, Paulos CM, Lesinski GB.
Ware MB, et al.
JCI Insight. 2023 Apr 24;8(8):e155006. doi: 10.1172/jci.insight.155006.
JCI Insight. 2023.
PMID: 36881480
Free PMC article.